Fair Value Calculator Fair Value Calculator
EN DE

GENUSPRIME (GENUSPRIME) Fair Value & Analysis

IN · Market cap ₹2.4B

G GENUSPRIME GENUSPRIME · BSE
Price₹31.12
Fair Value₹4.13
Upside-86.7%
Quality50/100
Watch GENUSPRIME for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹4.13 – ₹14.40

Fair value as of: Jul 5, 2026

From 23 valuation models · updated today

Share price +10.8% over the past month.

Price vs Fair Value (12 months)

₹34.71 ₹17.87 Fair Value ₹4.13 Jul 2025 Jul 2026

12‑month range ₹17.87 – ₹34.71 · fair‑value band ₹4.13 – ₹14.40 · the ₹31.12 price screens above the ₹4.13 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

GENUSPRIME (GENUSPRIME) currently trades at ₹31.12, while our model-based Fair Value estimate is ₹4.13 — implying the stock looks roughly 86.7% overvalued today. We read business quality at 50/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Trailing-twelve-month revenue stands at ₹42.4M. It earns a return on equity of 3.4%. Net debt stands at ₹400M. The stock trades on a trailing P/E of 8.7. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹4.13 (bear case) to ₹14.40 (bull case); at ₹31.12, the current price sits above that range. The share trades about 14% below its 52-week high and 79% above its 52-week low, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹42.4M
Revenue growth (YoY) +6,508%
Net margin 108%
Return on equity 3.4%
Free cash flow ₹8.5M FY2026
P/E ratio 8.7
More key figures
Operating margin 117%
EPS (TTM) ₹3.59
EPS growth (YoY) +19,543%
Net debt ₹400M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

GENUSPRIME reported revenue of ₹42.4M in FY2026 versus ₹2.2M in FY2022, a compound +108.9%/yr. Reported net income was ₹45.9M in FY2026.

Revenue +108.9%/yr
FY22 ₹2.2M
FY23 ₹2.2M
FY24 ₹2.3M
FY25 ₹2.2M
FY26 ₹42.4M
Net income
FY22 −₹3.6M
FY23 −₹77.0K
FY24 −₹20.0M
FY25 −₹367K
FY26 ₹45.9M

Is GENUSPRIME fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "GENUSPRIME Fair Value". https://www.fairvalue-calculator.com/stock/GENUSPRIME

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is GENUSPRIME (GENUSPRIME) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹4.13 versus a price of ₹31.12 — about −87% (overvalued). Model-based estimate, not financial advice.
What is the fair value of GENUSPRIME?
Our model-based fair value for GENUSPRIME is ₹4.13 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹31.12.
What is the quality score of GENUSPRIME?
GENUSPRIME has a Quality Score of 50/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of GENUSPRIME (GENUSPRIME)?
GENUSPRIME reported trailing-twelve-month revenue of about ₹42.4M (latest available figure, as of Jul 5, 2026).
What is the net profit margin of GENUSPRIME?
The net profit margin of GENUSPRIME is about 108.1%, meaning it keeps roughly 108.1% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.